100% agree.
The tech can be adapted to suit 100,s of applications/products already being sold. I see it as a cost effective upsell that will have HUGE appeal in the FMCG's space...... think 5 new companies generating royalties from multiple products. The key here is MULTIPLES. For example - 5 new products per company equates to 25 royalty income streams annually. The numbers and potential income are simply staggering when you consider global acceptance moving forward.
Exciting times indeed.
Regards HB
- Forums
- ASX - By Stock
- WFL
- Wellfully Group
Wellfully Group, page-37
-
-
- There are more pages in this discussion • 293 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online